Article:
https://link.springer.com/chapter/10.1007/978-3-031-33533-4_4
https://link.springer.com/content/pdf/10.1007/978-3-031-33533-4.pdf
Full book:
https://www.researchgate.net/publication/377197995_The_Evolution_of_nca_177Lu_to_nca_177Lu-Edotreotide_for_the_Treatment_of_Neuroendocrine_Tumours_Sixteen_Years_of_Collaboration_Between_Zentralklinik_Bad_Berka_and_ITM/fulltext/65994ea42468df72d3fd4ce9/The-Evolution-of-nca-177Lu-to-nca-177Lu-Edotreotide-for-the-Treatment-of-Neuroendocrine-Tumours-Sixteen-Years-of-Collaboration-Between-Zentralklinik-Bad-Berka-and-ITM.pdf?_tp=eyJjb250ZXh0Ijp7ImZpcnN0UGFnZSI6InB1YmxpY2F0aW9uIiwicGFnZSI6InB1YmxpY2F0aW9uIn19
06 January 2024
- Forums
- ASX - By Stock
- TLX
- Nuclear Medicine: From Concept to Clinic and Commercialization (CB chapter in Pr. Richard Baum tribute book)
Nuclear Medicine: From Concept to Clinic and Commercialization (CB chapter in Pr. Richard Baum tribute book)
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$17.80 |
Change
0.320(1.83%) |
Mkt cap ! $5.956B |
Open | High | Low | Value | Volume |
$17.83 | $17.88 | $17.43 | $15.18M | 856.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2418 | $17.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.80 | 18320 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2418 | 17.790 |
2 | 2402 | 17.780 |
1 | 1380 | 17.770 |
1 | 2795 | 17.750 |
1 | 134 | 17.740 |
Price($) | Vol. | No. |
---|---|---|
17.800 | 18320 | 1 |
17.870 | 1586 | 3 |
17.910 | 1000 | 1 |
17.920 | 6381 | 2 |
17.950 | 1000 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEWS
Is oil undervalued?
TLX (ASX) Chart |